Study to Understand Clinical Characteristics, Treatment Pathway in Chronic Lymphocytic Leukemia

CompletedOBSERVATIONAL
Enrollment

1,088

Participants

Timeline

Start Date

December 3, 2021

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions
Chronic Lymphocytic Leukemia
Trial Locations (52)

1330

Research Site, Adana/Saricam

1409

Research Site, São Paulo

6230

Research Site, Ankara/Altindag

6560

Research Site, Ankara/Yenimahalle

10103

Research Site, Santo Domingo. D.N.

10203

Research Site, San José

11001

Research Site, Abu Dhabi

11426

Research Site, Riyadh

11566

Research Site, Cairo

11591

Research Site, Alexandria

Research Site, Cairo

11796

Research Site, Cairo

12231

Research Site, Riyadh

12611

Research Site, Cairo

21423

Research Site, Jeddah

35100

Research Site, Izmir/ Bornova

35330

Research Site, Izmir/Balcova

42262

Research Site, Kuwait City

47500

Research Site, Kuala Selangor

55280

Research Site, Samsun/Atakum

59100

Research Site, Kuala Lumpur

64460

Research Site, Monterrey

68000

Research Site, Kuala Selangor

80100

Research Site, Johor Bahru

85863

Research Site, Luxor

100225

Research Site, Taipei

110005

Research Site, Delhi

110017

Research Site, Delhi

110111

Research Site, Bogotá

119228

Research Site, Singapore

121001

Research Site, Faridabad

122002

Research Site, Haryāna

168582

Research Site, Singapore

190011

Research Site, Kashmīr

308433

Research Site, Singapore

380009

Research Site, Ahmedabad

400012

Research Site, Mumbai

407219

Research Site, Taichung

500082

Research Site, Hyderabad

560017

Research Site, Manipal

711103

Research Site, Kolkata

760045

Research Site, Santiago de Cali

7500000

Research Site, Providencia

C1114

Research Site, Buenos Aires

C1115

Research Site, Buenos Aires

13083-887

Research Site, Campinas

17210-080

Research Site, Jaú

01236-030

Research Site, São Paulo

04502-001

Research Site, São Paulo

050010

Research Site, Medellín

06726

Research Site, Mexico City

Panama 4

Research Site, Panama City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT04964908 - Study to Understand Clinical Characteristics, Treatment Pathway in Chronic Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter